NASDAQ:OCUL | Free Cash Flow | OCULAR THERAPEUTIX, INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$65.99M$4.66M-$70.66M
2025-12-31-$54.25M$2.84M-$57.09M
2025-03-31-$44.67M$1.93M-$46.6M
2024-12-31-$39.43M$202,000.00-$39.63M
2024-03-31-$33.89M$255,000.00-$34.14M
2023-12-31-$22.45M$459,000.00-$22.91M
2023-03-31-$19.97M$3.38M-$23.35M
2022-12-31-$16.96M$2.15M-$19.11M
2022-03-31-$18.6M$276,000.00-$18.88M
2021-12-31-$15.15M$631,000.00-$15.78M
2021-03-31-$17.36M$158,000.00-$17.52M-561.26%
2020-12-31-$6.25M$253,000.00-$6.5M
2020-03-31-$18.85M$249,000.00-$19.1M
2019-12-31-$19.47M$601,000.00-$20.07M
2019-03-31-$19.39M$725,000.00-$20.11M
2018-12-31-$13.65M$479,000.00-$14.13M
2018-03-31-$12.47M$381,000.00-$12.85M
2017-12-31-$10.38M$564,000.00-$10.95M
2017-03-31-$14.58M$1.65M-$16.23M
2016-12-31-$7.61M$680,000.00-$8.29M
2016-03-31-$9.26M$127,000.00-$9.38M
2015-12-31-$8.64M$473,000.00-$9.11M
2015-03-31-$6.88M$354,000.00-$7.23M
2014-12-31-$5.63M$441,000.00-$6.07M
2014-03-31-$4.03M$297,000.00-$4.32M
2013-12-31-$3.46M$206,000.00-$3.66M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$204.88M$12.01M-$216.89M
2024-12-31-$134.68M$1.29M-$135.97M
2023-12-31-$70.23M$6.09M-$76.32M
2022-12-31-$59.6M$3.72M-$63.32M
2021-12-31-$65.55M$1.19M-$66.74M
2020-12-31-$53.55M$841,000.00-$54.4M
2019-12-31-$77.58M$2.24M-$79.82M
2018-12-31-$49.23M$1.89M-$51.12M
2017-12-31-$50.47M$8.25M-$58.73M
2016-12-31-$34M$1.92M-$35.92M
2015-12-31-$33.74M$1.78M-$35.52M
2014-12-31-$20.5M$1.26M-$21.76M
2013-12-31-$12.65M$387,000.00-$13.03M
2012-12-31-$12.59M$203,000.00-$12.79M